Brain Canada Brain Canada
FR Donate

For Researchers

Funding the very best Canadian neuroscience, fostering collaborative research and accelerating the pace of discovery, in order to improve the health and quality of life of Canadians who suffer from brain disorders.

Latest competition updates

Five Canadian-led teams receive international grants to advance research on Alzheimer’s disease and dementia

March 22, 2022

Current Funding Opportunities

Together, Brain Canada and the ALS Society of Canada are pleased to announce the continuation of the Discovery Grant Program. The purpose of this program is to invest in the best possible projects that are focused on identifying causes of, or treatments for ALS and/or related neurological diseases, or research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to persons or families living with ALS.

The 2022 ALS Canada – Brain Canada Discovery Grant Program consists of two streams that will fund novel and innovative research approaches, supported by sound rationale and a feasible experimental plan:

Stream 1 : Aimed at nurturing novel ideas looking to obtain preliminary data or to pursue ideas supported by very early data signals. Up to six awards of up to $125,000 will be awarded in this cycle.

Stream 2 : Aimed at funding more ambitious projects that are supported with some level of preliminary data to justify the larger investment. Up to two awards of up to $300,000 will be awarded in this cycle.

Evidence clearly shows that increasing equity, diversity and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and ALS Canada are committed to excellence through equity and encourage applicants of diverse backgrounds to apply to our funding opportunities. 

Click here to view the Terms of Reference. 

Deadline for receipt of Full Applications: July 5, 2022 at 13:00 ET

Together, Brain Canada, the Canadian Stroke Consortium, and Heart &Stroke are pleased to launch the 2022 Stroke Clinical Research Catalyst Grant program. This funding opportunity will provide seed funding to develop new lines of research and generate preliminary data that would support successful applications to larger grants from granting agencies, while broadening the researcher’s clinical research program.

Up to ten grants of $100,000 each over two years will be awarded through this new program, with a minimum of four of these grants intended for early-career investigators.

Click here to view the Request for Applications.

Deadline to register: May 31, 2022 at 16:00 ET

Deadline for receipt of Full Applications: August 5, 2022 at 16:00 ET

Published on:
April 21, 2022

Supporting the next generation of brain researchers in Canada is needed to ensure the success of the Canadian brain research ecosystem. The Brain Canada Rising Stars Trainee Awards aim to recognize the excellent research being conducted at Canadian institutions by graduate students (M.Sc., Ph.D.), postdoctoral fellows, and residents in all fields spanning neuroscience research.

2022 Trainee Award Opportunities :

Shireen and Edna Marcus Excellence Award

  • Purpose: To provide financial support to promising graduate students, postdoctoral fellows and/or residents conducting research in autism.
  • Amount of award: $4,500 per award for one year, non-renewable.
  • Number of awards: Up to 1 award.

Dr. Hubert van Tol Travel Fellowship

  • Purpose: To allow graduate students (M.Sc., Ph.D.) and postdoctoral fellows to attend a major international conference/symposium or training course.
  • Amount of award: $5,000 per one award, non-renewable.
  • Number of awards: Up to 4 awards.

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

  • Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting neuroscience research at a Canadian institution in the field of cannabis/cannabinoid research.  
  • Amount of award: $10,000 per award for one year, non-renewable.
  • Number of awards: Up to 2 awards.

Dr. Matthew Galati Brain Changer Award

  • Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting clinical implementation research at a Canadian institution in the field of acquired brain injury.  
  • Amount of award: $10,000 per award for one year, non-renewable.
  • Number of awards: Up to 2 awards.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity and encourages applicants of diverse backgrounds to apply to this funding opportunity, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

Click here to view the Request for Application. 

Deadline for receipt of Applications: June 2, 2022 at 16:00 ET


Should you have any questions, please contact programs@braincanada.ca

Together with the Quebec Consortium for Drug Discovery (CQDM), Brain Canada is pleased to share an upcoming funding opportunity for Canadian researchers. CQDM’s Quantum Leap pharma-led funding program for drug discovery research aims to support innovative translational biopharmaceutical research projects that are at advanced stages of development and that have the potential to improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs.

Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

Brain Canada is partnering with the Quantum Leap pharma-led funding program for drug discovery research on eligible brain related projects.

Please note: Budget structures can vary depending on each project, please contact CQDM to confirm eligibility before applying.

For more details, please email CQDM at appliquez-apply@cqdm.org and visit their website here

Funding for the Quantum Leap partnership has been made possible thanks to Brain Canada and the CQDM.

Call for proposals are open year-round for Quantum Leap projects.

Deadline to participate in the next selection round : May 19, 2022.

Recently Closed Competitions

Published on:
February 25, 2022

Brain Canada is pleased to be partnering with ALS Canada to launch the 2022 ALS Canada-Brain Canada Trainee Program.

This funding opportunity is open to eligible trainees at the doctoral or postdoctoral level. Applicants will have demonstrated contributions to research that may or may not have related directly to ALS,  but proposed future research and training must be ALS-related. Please see the Terms of Reference for information regarding the funding opportunity and eligibility criteria.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. ALS Canada and Brain Canada are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

Click here to view the Terms of Reference

Deadline for receipt of Applications: April 8, 2022 at 13:00 ET

Brain Canada is pleased to be partnering with Cancer Research Society to launch the Brain Canada – Cancer Research Society Translational Research Grants program. This funding opportunity will support basic researchers and clinicians as they work together to translate research into novel approaches for the study, diagnosis, and/or treatment of pediatric and adult brain cancer.

Two grants of $1,000,000 each will be awarded through this new funding opportunity. Successful teams must include the collaborative work of an early-career investigator and a senior investigator in either the basic and/or clinical research fields. 

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and Cancer Research Society are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities.

Click here to view the Request for Applications.

Deadline to register: March 23, 2022 at 16:00 ET

Deadline for receipt of Full Applications: May 13, 2022 at 16:00 ET

Together with the Quebec Consortium for Drug Discovery (CQDM), Brain Canada is pleased to share an upcoming funding opportunity for Canadian researchers. CQDM’s Quantum Leap pharma-led funding program for drug discovery research aims to support innovative translational biopharmaceutical research projects that are at advanced stages of development and that have the potential to improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs.

Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

Brain Canada is partnering with the Quantum Leap pharma-led funding program for drug discovery research on eligible brain related projects.

Please note: Budget structures can vary depending on each project, please contact CQDM to confirm eligibility before applying.

For more details, please email CQDM at appliquez-apply@cqdm.org and visit their website here

Funding for the Quantum Leap partnership has been made possible thanks to Brain Canada and the CQDM.

Call for proposals are open year-round for Quantum Leap projects.

Deadline to participate in the next selection round : February 24, 2022.

The European Union Joint Programme on Neurodegenerative Disease Research (JPND), a global research initiative with 30 member countries, has launched a transnational call for research projects on understanding the mechanisms of non-pharmacological interventions for Alzheimer’s disease, Parkinson’s disease, motor neuron disease and other neurodegenerative diseases.

Together, Brain Canada and Canadian Institutes of Health Research (CIHR) will support up to 3 projects (max. amount $333,000 per grant over 3 years). Brain Canada funds will go toward one project with a focus on Parkinson’s disease, and CIHR funds are available to support research relevant to any area of the JPDN call.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and CIHR are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities.

Click here for more information.  

Deadline for receipt of pre-proposals: March 1, 2022, at 6:00 a.m. ET

Deadline for full proposals: June 28, 2022, at 6:00 a.m. ET

Frequently Asked Questions

I would like to have some information on your upcoming grant programs.

Please see the link for current funding opportunities.

Is a non-Canadian researcher allowed to participate on a grant?

Most Brain Canada funding is restricted to distribution in Canada.

However, if the matched funding or partner allows for fund disbursal in the US, then a non-Canadian researcher may be able to participate in a grant administered by Brain Canada.

We would like to acknowledge Brain Canada on our website. Could we have a high resolution version of your logo?

Please contact us to obtain a high resolution version of our logo.

Where can I view the results of the latest competition?

We do not post competition results until the awardees have provided the signed Notice of Conditional grant to Brain Canada. Results will be posted on the Brain Canada website.

Questions?

Email: info@braincanada.ca

Telephone: +1 (514) 989-2989

Follow us:

Facebook Twitter

Sign up for Funding Alerts

SIGN UP